Research Article
Mortality Predictors and Survival Analysis in Cervical Cancer Patients Treated with Brachytherapy: A Retrospective Study at RMCH
Issue:
Volume 10, Issue 4, December 2024
Pages:
56-65
Received:
20 November 2024
Accepted:
2 December 2024
Published:
19 December 2024
DOI:
10.11648/j.rst.20241004.11
Downloads:
Views:
Abstract: Cervical cancer remains a significant health burden, particularly in low- and middle-income countries, where over 85% of cases occur. Bangladesh exhibits crude incidence and mortality rates of 10.2 and 6.1 per 100,000, respectively, highlighting the impact of cervical cancer. This retrospective study, conducted at Rajshahi Medical College Hospital, assessed 141 cervical cancer patients treated with brachytherapy between December 2016 and December 2020. The primary objective was to examine survival outcomes and associated mortality factors in relation to the stage of cervical cancer at diagnosis. The study revealed that 59 patients (42%) were alive at the time of analysis, of which 88% had achieved disease-free survival. Conversely, 35 patients (25%) were deceased, with advanced-stage disease being predominant among them. Renal failure was identified as the leading cause of death (37%). Results suggest that early-stage cervical cancer correlates with improved survival outcomes, underscoring the necessity of early detection and prompt treatment. Despite the curative potential of brachytherapy when combined with external beam radiotherapy and cisplatin-based chemotherapy, global disparities in access to brachytherapy hinder effective cervical cancer management, particularly in low-resource settings. Enhanced screening programs, vaccination efforts, and broader access to advanced treatment modalities, including brachytherapy, are critical in reducing cervical cancer-related mortality in low- and middle-income countries.
Abstract: Cervical cancer remains a significant health burden, particularly in low- and middle-income countries, where over 85% of cases occur. Bangladesh exhibits crude incidence and mortality rates of 10.2 and 6.1 per 100,000, respectively, highlighting the impact of cervical cancer. This retrospective study, conducted at Rajshahi Medical College Hospital,...
Show More
,
Karim Md. Abdul
